Based on recently completed studies and epidemiologic data, FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply.
Read MoreThe Diazyme DZ-Lite SARS-CoV-2 IgG and SARS-CoV-2 IgM CLIA test kits are run on the fully automated Diazyme DZ-Lite 3000 Plus chemiluminescence analyzer.
Read MoreThe DPP Covid-19 IgM/IgG system is a single-use rapid point-of-care test for the detection and differentiation of IgM and IgG antibodies to covid-19 in whole blood.
Read MoreThe covid-19 antibody test works in 15 minutes, and features an intuitive visual interpretation. No special equipment is needed.
Read More
Together with previous coverage decisions for two GTC hematology profiling tests, the MolDx coverage determination will permit GTC to offer comprehensive genomic profiling for patients with all types of cancer.
Read More